TickerFactsScreenerDevelopers

NovoCure Ltd (NVCR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$107.59M2017: -$33.13M2018: -$1.86M2019: $26.62M2020: $99.15M2021: $82.76M2022: $30.79M2023: -$73.34M2024: -$26.37M2025: -$49.03M-$49.03M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$49.03M-85.9%
2024-$26.37M+64.0%
2023-$73.34M-338.2%
2022$30.79M-62.8%
2021$82.76M-16.5%
2020$99.15M+272.5%
2019$26.62M+1527.3%
2018-$1.86M+94.4%
2017-$33.13M+69.2%
2016-$107.59M—